人工角膜と角膜インプラントの市場規模、シェア、成長分析、タイプ別、移植タイプ別、適応疾患別、エンドユーザー別、地域別 - 産業予測、2025-2032年

人工角膜と角膜インプラントの世界市場規模は、2023年に4億5,420万米ドルと評価され、2024年の4億8,781万米ドルから2032年には8億6,355万米ドルに成長し、予測期間（2025年～2032年）のCAGRは7.4％で成長する見通しです。

人工角膜と角膜インプラント市場は、眼科疾患の有病率の上昇と眼科医療への投資意欲の高まりにより、大きな成長が見込まれています。献眼に対する意識の高まりと臓器提供者登録の急増は、市場拡大にさらに拍車をかけています。さらに、信頼性の高い眼球移植手術へのアクセス向上と眼科医療に対する費用償還政策の改善が売上を促進すると予想されます。しかし、特定の地域では、これらのインプラントに関連するコストが高いため、市場開拓の妨げになる可能性があります。特筆すべきは、世界中で急速に増加する老人人口が、人工角膜と角膜インプラントの持続的な需要を生み出し、今後数年間この市場は長期的成長が見込まれています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

人工角膜と角膜インプラント市場規模：タイプ別

• 市場概要
• ヒト角膜
• 人工角膜

人工角膜と角膜インプラント市場規模：移植タイプ別

• 市場概要
• 全層角膜移植
• 内皮角膜移植
• 前層角膜移植
• 角膜プロテーゼ

人工角膜と角膜インプラント市場規模：適応疾患別

• 市場概要
• フックスジストロフィー
• 真菌性角膜炎
• 円錐角膜
• その他

人工角膜と角膜インプラント市場規模：エンドユーザー別

• 市場概要
• 病院および外来手術センター
• 専門クリニック

人工角膜と角膜インプラント市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• CorNeat Vision（Israel）
• KeraMed, Inc.（USA）
• LinkoCare Life Sciences AB（Sweden）
• DIOPTEX GmbH（Austria）
• EyeYon Medical（Israel）
• AJL Ophthalmic SA（Spain）
• Mediphacos（Brazil）
• CorneaGen（USA）
• Florida Lions Eye Bank（USA）
• San Diego Eye Bank（USA）
• Alabama Eye Bank（USA）
• Massachusetts Eye and Ear（USA）
• Advancing Sight Network（USA）
• L V Prasad Eye Institute（LVPEI, India）
• Alcon Inc.（Switzerland）
• Aurolab（India）
• Cornea Biosciences（USA）
• Price Vision Group（USA）

結論と推奨事項

Global Artificial Cornea and Corneal Implant Market size was valued at USD 454.2 million in 2023 and is poised to grow from USD 487.81 million in 2024 to USD 863.55 million by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The artificial cornea and corneal implant market is anticipated to experience significant growth due to the rising prevalence of ophthalmic diseases and an increasing consumer willingness to invest in eye care. Heightened awareness of eye donation and a surge in organ donor registries are further fueling market expansion. Additionally, enhanced access to reliable eye transplant procedures and improved reimbursement policies for eye care are expected to drive sales. However, high costs associated with these implants in certain regions may hinder market development. Notably, the rapidly growing geriatric population worldwide will create sustained demand for artificial corneas and corneal implants, positioning the market for long-term growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea And Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea And Corneal Implant Market Segmental Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea And Corneal Implant Market

The rising incidence of corneal disorders is a significant driver for the Global Artificial Cornea and Corneal Implant market. This increase can be attributed to both an aging population and greater exposure to screens, which have heightened the occurrence of these conditions globally. As the need for corneal transplants grows in response to these disorders, there will be an escalated demand for artificial corneas and corneal implants. Consequently, advancements in technology and medical procedures are expected to further spur market growth, addressing the needs arising from this escalating health concern.

Restraints in the Global Artificial Cornea And Corneal Implant Market

One significant constraint facing the Global Artificial Cornea and Corneal Implant market is the limited reimbursement options for corneal transplantation procedures. Many healthcare insurance plans do not comprehensively cover these surgeries, forcing patients to bear the high costs out-of-pocket. This financial burden often discourages individuals from pursuing such critical procedures, ultimately hindering market growth. The high expenses associated with corneal transplants create a barrier that could prevent broader accessibility and adoption, limiting the potential for advancements and expansions within the artificial cornea and implant sector. As a result, the market may struggle to thrive amid these financial challenges.

Market Trends of the Global Artificial Cornea And Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market is increasingly trending towards the adoption of minimally invasive surgical techniques, as patients prioritize quicker recovery times and reduced surgical risks. This shift has prompted product developers to innovate and streamline their offerings, making advanced corneal solutions more accessible to both surgeons and patients. Additionally, enhancing reimbursement policies for these procedures is becoming critical, as it can significantly boost the uptake of artificial corneas and implants. As healthcare systems evolve to support these trends, market players must adapt their strategies to capitalize on the growing demand for effective, less invasive ocular treatments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Cornea
• Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
• keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2025-2032)

• North America (Type, Transplant Type, Disease Indication, End User)
  • US
  • Canada
• Europe (Type, Transplant Type, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Transplant Type, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Transplant Type, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorNeat Vision (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KeraMed, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LinkoCare Life Sciences AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• San Diego Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alabama Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Massachusetts Eye and Ear (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advancing Sight Network (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L V Prasad Eye Institute (LVPEI, India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cornea Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Price Vision Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations